Clinical Trials
2 trialsNCT05580172 2022-10-17
Phase 1 Study of Oral RH324 in Advanced Non-Small Cell Lung Cancer
ReHeva Biosciences,Inc.
Phase 1 Unknown
NCT03620435 2018-08-13
Trimodal Therapy Plus Atezolizumab in Muscle-invasive Bladder Cancer
McGill University Health Centre/Research Institute of the McGill University Health Centre
Phase 2 Unknown